Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vaxart Inc | VXRT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.028 | -5.0% | 0.532 | 0.5701 | 0.52 | 0.54 | 0.56 | 12:13:32 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.532 | 0.5399 | 0.008 | 1.48% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 714 | 305,814 | $ 0.5435189 | $ 166,216 | 306,522 | 0.52 - 7.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:13:32 | 1,100 | $ 0.532 | USD |
Vaxart Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 8.40M | 15.79M | $ -18.01M | -2.34 | - | 13.22M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Vaxart News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VXRT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.6648 | 0.668 | 0.52 | 0.5922 | 235k | -0.1328 | -19.98% |
| 1 Month | 0.67 | 0.7798 | 0.52 | 0.6736 | 352k | -0.138 | -20.60% |
| 3 Months | 0.7 | 0.922 | 0.52 | 0.6771 | 207k | -0.168 | -24.00% |
| 6 Months | 1.98 | 2.1999 | 0.52 | 0.8233 | 358k | -1.448 | -73.13% |
| 1 Year | 3.19 | 7.6 | 0.52 | 2.3064 | 443k | -2.658 | -83.32% |
| 3 Years | 18.15 | 22 | 0.52 | 4.9496 | 313k | -17.618 | -97.07% |
| 5 Years | 23.65 | 33 | 0.52 | 7.5666 | 216k | -23.118 | -97.75% |
Vaxart Description
| Vaxart Inc is a biopharmaceutical company. It is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The company has three product candidates which are; vapendavir, an oral treatment for human rhinovirus (HRV) upper respiratory infections in moderate-to-severe asthmatics; BTA585, an oral fusion protein inhibitor for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in for condyloma caused by human papillomavirus. |
